Galicaftor
- Generic Name
- Galicaftor
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C28H21F4NO7
- CAS Number
- 1918143-53-9
- Unique Ingredient Identifier
- J0IIT8QSQS
- Background
Galicaftor is under investigation in clinical trial NCT03540524 (A Study Looking at the Safety, Tolerability and Efficacy of the Combination of the Study Drugs GLPG2451 and GLPG2222 With or Without GLPG2737 in Patients With Cystic Fibrosis.).
- Associated Conditions
- -
- Associated Therapies
- -
A Study to Assess How Food Affects the Safety and Pharmacokinetics of Galicaftor and Navocaftor
- First Posted Date
- 2022-09-14
- Last Posted Date
- 2023-01-17
- Lead Sponsor
- AbbVie
- Target Recruit Count
- 24
- Registration Number
- NCT05538585
- Locations
- ๐บ๐ธ
Clinical Pharmacology of Miami /ID# 249531, Miami, Florida, United States
๐บ๐ธAcpru /Id# 249532, Grayslake, Illinois, United States
A Study to Assess the Pharmacokinetics and Safety of Co-administered Oral Galicaftor, Navocaftor, and ABBV-576 in Healthy Adults for the Treatment of Cystic Fibrosis
- Conditions
- Interventions
- First Posted Date
- 2022-09-07
- Last Posted Date
- 2023-02-21
- Lead Sponsor
- AbbVie
- Target Recruit Count
- 24
- Registration Number
- NCT05530278
- Locations
- ๐บ๐ธ
Anaheim Clinical Trials LLC /ID# 248824, Anaheim, California, United States
๐บ๐ธClinical Pharmacology of Miami /ID# 248823, Miami, Florida, United States
๐บ๐ธPPD Clinical Research Unit -Las Vegas /ID# 248853, Las Vegas, Nevada, United States
Study to Evaluate Adverse Events and Change in Disease Activity With Oral Capsules of Galicaftor/Navocaftor/ABBV-119 or Galicaftor/Navocaftor/ABBV-576 Combination Therapies in Adult Participants With Cystic Fibrosis
- Conditions
- Interventions
- First Posted Date
- 2021-04-21
- Last Posted Date
- 2024-07-16
- Lead Sponsor
- AbbVie
- Target Recruit Count
- 48
- Registration Number
- NCT04853368
- Locations
- ๐บ๐ธ
University of Southern California /ID# 249147, Los Angeles, California, United States
๐บ๐ธUH Cleveland Medical Center /ID# 245433, Cleveland, Ohio, United States
๐บ๐ธBoston Children's Hospital /ID# 248646, Boston, Massachusetts, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.